GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

Artificial intelligence is poised to transform healthcare, offering promising advancements in treatment and diagnosis, but experts urge caution regarding privac ...

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

What started as a ‘friendly conversation’ on the UNTHSC campus could lead to a breakthrough in treating glaucoma—the leading ...

Carolyn Adelsten woke up feeling like something was in her eye and it wouldn't come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.